Research Newsroom

CHLA-Fabbri-Muller web.jpg
Muller Fabbri, MD, PhD, of the Children’s Center for Cancer and Blood Diseases at Children’s Hospital Los Angeles, has been awarded $1.9 million by the National Cancer Institute of the NIH to further his research on neuroblastoma – the third most common type of childhood cancer...
21386-chla-placeholders_320x165_v2_0.jpg
More accurate diagnoses translate to more effective treatment and better outcomes Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease — a necessary step in achieving an optimum treatment. The research...
21386-chla-placeholders_320x165_v2_0.jpg
Preparing health care professionals to care for the next generation of adolescents and young adults Is California prepared to meet the specialized healthcare needs of the next generation of teens? According to the American Board of Pediatrics, there are only 51 physicians in...
CHLA-Guy-Young.jpg
New therapy decreases incidence of bleeding by nearly 90% An international team of hematologists including Guy Young, MD, of Children’s Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence...